Source Job

US

  • Serve as the primary liaison between Orca Bio and Authorized Treatment Centers, building trusted relationships with key stakeholders.
  • Coordinate treatment site readiness and operations, including identification, qualification, and product handling compliance.
  • Educate site personnel on approved therapies and clinical data while gathering market insights to inform strategy.

Account Management Cell Therapy Oncology Hematology Cross-functional Collaboration

6 jobs similar to Orca-T Account Manager

Jobs ranked by similarity.

US

  • Lead a small team of Orca-T Account Managers to execute commercial strategy for ORCA T®.
  • Collaborate cross-functionally with marketing, sales training, and sales operations to maximize teamwork.
  • Develop and monitor account activity, provide coaching, and ensure compliance.

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies for blood cancer patients. They maintain a start-up culture of camaraderie and leadership by example, with a focus on passion, courage, and integrity.

  • Serve as the primary operational liaison to NMDP and other registry partners across clinical and commercial programs.
  • Design, implement, and continuously improve scalable donor cell acquisition processes supporting the commercial launch of Orca-T and Orca Bio's clinical programs, incorporating transplant center feedback and industry best practices.
  • Assess capacity constraints in apheresis and patient operations infrastructure across the transplant center and registry network and proactively engage partners on solutions.

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies. With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.

US

  • Manage vendor apheresis collection accounts.
  • Build and maintain relationships with internal and external partners.
  • Track and improve vendor performance.

Dendreon is a biopharmaceutical company focused on the discovery, development, and commercialization of novel cancer therapies. They are an equal opportunity employer committed to diversity and inclusion.

US

  • Own territory performance by driving demand and adoption, and deliver on assigned sales objectives.
  • Develop and activate physician advocates who influence clinical adoption and broader hospital acceptance.
  • Build strong, trust based relationships with orthopedic surgeons, infectious disease specialists, and key clinical stakeholders.

Osteal Therapeutics is redefining the standard of care for life-altering orthopedic infections. They are a Dallas-based, privately held biotechnology company with $137M in funding and a distinguished investor base that includes strategic partners Johnson & Johnson and Zimmer Biomet.

  • Manage a portfolio of 10-12 academic medical centers and neuromuscular specialty centers as institutional commercial lead.
  • Lead formulary and pathway submissions, P&T committee presentations, and coordinate with payer and patient access teams.
  • Track KPIs, maintain CRM data, and present quarterly business reviews to executive leadership.

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, the company has an award-winning culture of innovation and employs over 10,000 people.

$220,000–$260,000/yr
US

  • Lead strategic account development and adoption to drive formulary access.
  • Build and influence senior stakeholder relationships to shape institutional decision-making.
  • Translate clinical and economic evidence into compelling value narratives.

Osteal Therapeutics is a Dallas-based, privately held biotechnology company redefining the standard of care for life-altering orthopedic infections. They are powered by $137M in funding to date and has a distinguished investor base that includes strategic partners Johnson & Johnson and Zimmer Biomet.